Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Delaying second Pfizer-BioNTech dose could leave cancer patients with insufficient immunity

Delaying second Pfizer-BioNTech dose could leave cancer patients with insufficient immunity

Researchers from the Crick and Imperial College have started work on a new study, funded by Kidney Research UK and the National Kidney Federation.
15 Mar 2021
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Colorised scanning electron micrograph of a T cell. Credit: NIAID
Research buzz

Water influx kicks immune cells into action

More...
Lung cancer cells can go ‘off grid’

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop … More...

The researchers liken the dual role of CDKN2A to the ancient Roman god of transitions Janus,
Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease

Researchers from the Crick and Barts have shown that a genetic fault long believed to drive the development of oesophage… More...

Teaser image credit: Ernesto del Aguila III, NHGRI
Uncovering the role of Y chromosome genes in male fertility in mice

More...

Tateossian, H. and Southern, A. et al. eLife
Genetic cause for main type of hearing loss in children with Down syndrome identified

Researchers at the Crick, MRC Harwell Institute and UCL Queen Square Institute of Neurology have identified the genetic … More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk


Check out

Community
Mentoring
Careers
News
Groups
Events

Legal

Terms
Privacy
Cookies
About
Contact

Alumni Management Software powered by
ToucanTech